AICDA and B-cell chronic lymphocytic leukemia: Notably, the interplay between AID-mediated DNA breaks and HR repair pathway has been used in clinically relevant studies wherein AID-expressing human chronic lymphocytic leukemia cells were shown to be hypersensitive to HR inhibitors, possibly due to AID-dependent synthetic cytotoxicity (139).